Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced multiple sclerosis in mice: Involvement of the PI3K/Akt/GSK-3β pathway-Reference-Cited by-同舟云学术

Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced multiple sclerosis in mice: Involvement of the PI3K/Akt/GSK-3β pathway

Published:2023-02 Issue: Volume:115 Page:109647
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Sadek Mohamed A,Kandil Esraa A,El Sayed Nesrine S,Sayed Helmy M,Rabie Mostafa A

Funder

Faculty of Veterinary Medicine, Cairo University

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference108 articles.

1. Multiple sclerosis;Yamout;Semin. Neurol.,2018

2. Multiple sclerosis: current knowledge and future outlook;Kamm;Eur. Neurol.,2014

3. Epidemiology of multiple sclerosis: from risk factors to prevention-an update;Ascherio;Semin. Neurol.,2016

4. Cognitive aspects in multiple sclerosis;Lisak;Psychiatr. Danub.,2021

5. Walton, C., et al., Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler, 2020. 26(14): p. 1816-1821.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Semaglutide ameliorated autism-like behaviors and DNA repair efficiency in male BTBR mice by recovering DNA repair gene expression;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-12

2. Vortioxetine ameliorates experimental autoimmune encephalomyelitis model of multiple sclerosis in mice via activation of PI3K/Akt/CREB/BDNF cascade and modulation of serotonergic pathway signaling;European Journal of Pharmacology;2024-11

3. Dihydroartemisinin ameliorates experimental autoimmune myasthenia gravis by regulating CD4+ T cells and modulating gut microbiota;International Immunopharmacology;2024-09

4. The Role of Glucagon-Like Peptide-1 Agonists in the Treatment of Multiple Sclerosis: A Narrative Review;Cureus;2024-08-19

5. To the Brain and Beyond: Neurological Implications of Glucagon-Like Peptide-1 Receptor Agonists;Journal of Neurosurgical Anesthesiology;2024-07-31